Surgery vs Chemoradiation for Esophageal Cancer

Chemoradiation Versus Esophagectomy for Locally Advanced Esophageal Cancer

Recruiting N/A Interventional Study
Esophagus Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 75
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
196 (estimated)
Sponsor
The First Affiliated Hospital of Henan University of Science and Technology · Other
Who this trial is looking for

This trial is looking for Chinese patients with locally advanced esophageal squamous cell cancer. Participants will receive either surgery or a combination of chemotherapy and radiation treatment.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am Chinese
  • I have been diagnosed with esophageal squamous cell cancer
  • I have mid or lower esophageal cancer
  • My tumor can be removed by surgery
  • My cancer stage is cT1bN+Mo or cT2-4aN0-2M0

You may not be able to join if

  • I have distant metastasis to solid organs
  • I have local invasion into the trachea, descending aorta, or recurrent laryngeal nerve
  • I have a serious condition that affects my physical status for surgery

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The aim of this study is to compare outcomes in Chinese patients with locally advanced resectable esophageal squamous cell cancer who have received either surgery or definitive chemoradiation (CRT) by the randomized, open-label, multicenter trial.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Chinese * esophageal squamous cell cancer * mid or lower esophageal cancer * tumor is resectable disease * clinical stage: cT1bN+Mo, or cT2-4aN0-2M0 Exclusion Criteria: * who had distant metastasis to solid visceral organs or local invasion into trachea, descending aorta, or…
Contacts

Shegan Gao, MD, PhD

+86 18638859977

gsg112258@163.com

CONTACT

Ruinuo Jia, MD

+86 18537950766

jiaruinuo@163.com

CONTACT